We are a genome editing company developing genetic medicines for the fight against rare pediatric diseases.
GeneRide™ is a promoterless and nuclease-free approach to gene insertion which may improve the safety profile of AAV based gene therapies
With GeneRide™, the therapeutic gene is site-specifically integrated into the genome allowing durable gene expression in dividing cells and mature tissues. Furthermore, therapeutic gene expression is regulated by the targeted locus so production can be limited to specific cell types.
Location: United States, Massachusetts, Lexington
Employees: 51-200
Total raised: $49M
Founded date: 2014
Investors 5
| Date | Name | Website |
| - | Andera Par... | anderapart... |
| - | OrbiMed | orbimed.co... |
| - | Arix Biosc... | arixbiosci... |
| - | Horizon Te... | horizontec... |
| - | Pontifax V... | pontifax.c... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 29.06.2017 | Series B | $45M | Arix Biosc... |
| 21.01.2016 | - | $4M | - |
Mentions in press and media 10
| Date | Title | Description | Source |
| 04.10.2022 | A top Wall Street analyst names 3 tiny biotechs that look li... | The British pharma giant AstraZeneca has quietly been working on gene-editing research over the past... | businessin... |
| 05.05.2021 | LOGICBIO THERAPEUTICS, INC. LogicBio Therapeutics : Announc... | LEXINGTON, Mass. - LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a clinical-stage genetic medicine comp... | marketscre... |
| 27.04.2021 | ARIX BIOSCIENCE PLC LogicBio announces clinical and corpora... | Arix Bioscience PLC (ARIX) LogicBio announces clinical and corporate updates 27-Apr-2021 / 14:00 GMT... | marketscre... |
| 30.06.2017 | Term Sheet — Friday, June 30 | ET CETERA New Money: Headspace, a Los Angeles-based maker of a meditation app, has raised $36.7 mil... | fortune.co... |
| 29.06.2017 | LogicBio Therapeutics Raises $45M in Series B Funding | LogicBio Therapeutics Inc., a Cambridge, MA-based gene therapy company, raised $45m in Series B fina... | finsmes.co... |
| 29.06.2017 | Arix Bioscience Leads $45M Series B for LogicBio Therapeutic... | Arix Bioscience plc (LSE: ARIX), a global healthcare and life science company supporting medical inn... | citybizlis... |
| 28.06.2017 | Arix Bioscience leads $45 million Series B financing round i... | - | arixbiosci... |
| 28.06.2017 | Arix leads $45M series B for gene therapy biotech LogicBio | LogicBio Therapeutics has got off a $45 million series B funding round as it eyes the cash for disea... | fiercebiot... |
| 21.01.2016 | OrbiMed-backed LogicBio raises $4M for hemophilia gene thera... | The company was founded in 2014 by Adi Barzel, a former Stanford University post-doc who completed h... | medcitynew... |
| - | OrbiMed-backed LogicBio raises $4M for hemophilia gene thera... | LogicBio Therapeutics, a gene therapy startup backed quietly by OrbiMed Advisor’s Israeli arm, is in... | medcitynew... |